These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 14561997

  • 1. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation.
    Lee JJ, Nam CE, Kook H, Maciejewski JP, Kim YK, Chung IJ, Park KS, Lee IK, Hwang TJ, Kim HJ.
    Bone Marrow Transplant; 2003 Nov; 32(9):947-52. PubMed ID: 14561997
    [Abstract] [Full Text] [Related]

  • 2. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
    Lee J, Kook H, Chung I, Kim H, Park M, Kim C, Nah J, Hwang T.
    Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
    [Abstract] [Full Text] [Related]

  • 3. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
    Villaron EM, Almeida J, López-Holgado N, Alcoceba M, Sánchez-Abarca LI, Sanchez-Guijo FM, Alberca M, Pérez-Simon JA, San Miguel JF, Del Cañizo MC.
    Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
    [Abstract] [Full Text] [Related]

  • 4. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.
    Rieger K, Marinets O, Fietz T, Körper S, Sommer D, Mücke C, Reufi B, Blau WI, Thiel E, Knauf WU.
    Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839
    [Abstract] [Full Text] [Related]

  • 5. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, Tschiedel S, Cross M, Niederwieser D, Gentilini C.
    Transplantation; 2009 Jan 27; 87(2):217-21. PubMed ID: 19155975
    [Abstract] [Full Text] [Related]

  • 6. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation.
    Pozzi S, Lisini D, Podestà M, Bernardo ME, Sessarego N, Piaggio G, Cometa A, Giorgiani G, Mina T, Buldini B, Maccario R, Frassoni F, Locatelli F.
    Exp Hematol; 2006 Jul 27; 34(7):934-42. PubMed ID: 16797421
    [Abstract] [Full Text] [Related]

  • 7. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Jul 27; 216(6):356-63. PubMed ID: 15565551
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of mixed chimerism following allogeneic bone marrow transplantation using telomere flow-FISH.
    Martens UM, Waller CF, Lange W, Finke J.
    Ann Hematol; 2003 Jul 27; 82(7):416-22. PubMed ID: 12768321
    [Abstract] [Full Text] [Related]

  • 9. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, Rico MA, Bautista G, Krsnik I, Forés R, Ojeda E, Sanjuán I, García-Marco JA, Navarro B, Gil S, Sánchez R, Panadero N, Gutiérrez Y, García-Berciano M, Pérez N, Millán I, Cabrera R, Fernández MN.
    Cytotherapy; 2009 Jul 27; 11(3):278-88. PubMed ID: 19308773
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
    Koç ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W.
    Bone Marrow Transplant; 2002 Aug 27; 30(4):215-22. PubMed ID: 12203137
    [Abstract] [Full Text] [Related]

  • 11. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).
    Díez-Martín JL, Llamas P, Gosálvez J, López-Fernández C, Polo N, de la Fuente MS, Buño I.
    Haematologica; 1998 May 27; 83(5):408-15. PubMed ID: 9658724
    [Abstract] [Full Text] [Related]

  • 12. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.
    Kaiser S, Hackanson B, Follo M, Mehlhorn A, Geiger K, Ihorst G, Kapp U.
    Cytotherapy; 2007 May 27; 9(5):439-50. PubMed ID: 17786605
    [Abstract] [Full Text] [Related]

  • 13. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW, Wu DP, Zhu ZL, Wang W, Sun AN, Qiu HY, Fu ZZ, Chang WR, Ruan CG.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb 27; 25(2):78-81. PubMed ID: 14990044
    [Abstract] [Full Text] [Related]

  • 14. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
    Eguchi H, Kuroiwa Y, Matsui A, Sada M, Nagaya N, Kawano S.
    Transplant Proc; 2008 Mar 27; 40(2):574-7. PubMed ID: 18374132
    [Abstract] [Full Text] [Related]

  • 15. A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system.
    Gonçalves R, Lobato da Silva C, Cabral JM, Zanjani ED, Almeida-Porada G.
    Exp Hematol; 2006 Oct 27; 34(10):1353-9. PubMed ID: 16982328
    [Abstract] [Full Text] [Related]

  • 16. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
    Poloni A, Maurizi G, Rosini V, Mondini E, Mancini S, Discepoli G, Biasio S, Battaglini G, Felicetti S, Berardinelli E, Serrani F, Leoni P.
    Cytotherapy; 2009 Oct 27; 11(2):153-62. PubMed ID: 19301169
    [Abstract] [Full Text] [Related]

  • 17. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D, Zecca M, Giorgiani G, Montagna D, Cristantielli R, Labirio M, Grignani P, Previderè C, Di Cesare-Merlone A, Amendola G, Bergami E, Mastronuzzi A, Maccario R, Locatelli F.
    Haematologica; 2008 Dec 27; 93(12):1859-67. PubMed ID: 18945748
    [Abstract] [Full Text] [Related]

  • 18. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant.
    Stute N, Fehse B, Schröder J, Arps S, Adamietz P, Held KR, Zander AR.
    J Hematother Stem Cell Res; 2002 Dec 27; 11(6):977-84. PubMed ID: 12590713
    [Abstract] [Full Text] [Related]

  • 19. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice.
    Niemeyer P, Vohrer J, Schmal H, Kasten P, Fellenberg J, Suedkamp NP, Mehlhorn AT.
    Cytotherapy; 2008 Dec 27; 10(8):784-95. PubMed ID: 18951271
    [Abstract] [Full Text] [Related]

  • 20. Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis.
    Uckan D, Kilic E, Sharafi P, Kazik M, Kaya F, Erdemli E, Can A, Tezcaner A, Kocaefe C.
    Cytotherapy; 2009 Dec 27; 11(4):392-402. PubMed ID: 19337938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.